THY1 and neoplasm: CD90+ CSCs obtained from HCC cell lines, from tumor tissues and peripheral blood as circulating cancer cells displayed, in contrast to the other CSC populations, a mesenchymal phenotype and, most importantly, a greater capacity to metastasize when injected into immunodeficient mice [11, 12, 19].